Home » Authors » Peter O'Donnell

Articles by Peter O'Donnell

Biotech Innovators Asking For Tighter Biosimilar Naming Rules

Nov. 22, 2006

By Peter O'Donnell

Divisions Over Advanced Therapies Sharpen In EU

Nov. 15, 2006

By Peter O'Donnell

Divisions Over Advanced Therapies Sharpen In EU

Nov. 15, 2006

By Peter O'Donnell

European Union Tightens Rules On Human Cells And Tissues

Nov. 8, 2006

By Peter O'Donnell

European Union Tightens Rules On Human Cells And Tissues

Nov. 8, 2006

By Peter O'Donnell

Report from Europe: Ethics questions delay Europe s decision on advanced therapies

Nov. 2, 2006

By Peter O'Donnell

Ethics Questions Delay Europe's Decision On Advanced Therapies

Nov. 1, 2006

By Peter O'Donnell

Ethics Questions Delay Europe's Decision On Advanced Therapies

Nov. 1, 2006

By Peter O'Donnell

EU Advisory Group Bemoans Lack Of Biotechnology Progress

Oct. 25, 2006

By Peter O'Donnell

EU Advisory Group Bemoans Lack Of Biotechnology Progress

Oct. 25, 2006

By Peter O'Donnell

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...